Clinical Trial Update: Long Term Follow-Up Study for Individuals With Hemoglobin Disorders After Hematopoietic Cell Transplant or Gene Therapy

View source ↗

Summary

Long-term follow-up study to assess outcomes in individuals with hemoglobin disorders after hematopoietic cell transplantation or gene therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoglobinopathy

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Hemoglobin Disorder | Status: RECRUITING